Sun Pharmaceutical Industries rose 2.91% to Rs 404.80, extending recent gains on strong buying support.
Shares of Sun Pharmaceutical Industries rallied 9.74% in two trading sessions to its current market price of Rs 404.80 from its recent closing low of Rs 368.85 on Monday, 2 March 2020.
On the technical front, the stock's RSI (relative strength index) stood at 48.842. The RSI oscillates between zero and 100. Traditionally the RSI is considered overbought when above 70 and oversold when below 30.
The stock was trading between its 20-day moving average (DMA) placed at Rs 404.68 and 50-day moving average (DMA) placed at Rs 426.08.
Sun Pharmaceutical Industries' consolidated net profit tanked 26.4% to Rs 913.52 crore on a 5% increase in net sales to Rs 8,038.65 crore in Q3 December 2019 over Q3 December 2018.
Sun Pharmaceutical Industries' business segments include US Business, Indian branded generics business, Emerging markets, Global consumer healthcare business and Active Pharmaceutical Ingredients (API).
Powered by Capital Market - Live News